Navigation Links
Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
Date:7/12/2010

velopment programs, please visit www.alexza.com.

Safe Harbor Statement

This news release contains forward-looking statements that involve significant risks and uncertainties.  Any statement describing the expectations or beliefs of the Company or Addicere Therapeutics, Inc. is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement, including any such statements regarding financing of Addicere and development by Addicere of Staccato nicotine.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs.  The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements.  These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission, including the risks under the headings: "We have a history of net losses. We expect to continue to incur substantial and increasing net losses for the foreseeable future, and we may never achieve or maintain profitability.", "We will need substantial additional capital in the future. If additional capital is not available, we will have to delay, reduce or cease operations.", "Unless our preclinical studies demonstrate the safety of our product candidates, we will not be
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
2. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
3. Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference
4. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
5. Alexza Pharmaceuticals Files Shelf Registration Statement
6. Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
7. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
10. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
11. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 22, 2014  Sprout Pharmaceuticals today announced ... demonstrate that women treated with flibanserin up to 200 mg ... data were presented at the 20 th Annual Fall ... North America in Miami . ... response to the Complete Response Letter and the Formal Dispute ...
(Date:11/22/2014)...  New data demonstrates that flibanserin, a novel, non-hormonal ... female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does ... premenopausal women when taken at bedtime. The data was ... North America,s (SMSNA) 20th Annual Fall Scientific ... SMSNA accepted this study as a late breaking ...
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation ... its European Union approved CytoSorb® cytokine adsorber to ... awarded the Beacon of Light Award at last ... Dr. Phillip Chan , ... an honor to be recognized by the New ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
... Va., Aug. 19 MicroAire Surgical Instruments ... multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® ... soft tissue to bone, or to other soft tissue ... avoiding the tissue-strain associated with sutures. Although ...
... What is the fourth leading cause of death in the ... obstructive pulmonary disease (COPD) is, and the number of people ... than 12 million Americans are currently diagnosed with COPD and ... breath and coughing are in fact symptoms of this debilitating ...
Cached Medicine Technology:MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems) 2Supplemental Oxygen Company Offers Steps to Improve COPD Patients' Lives 2Supplemental Oxygen Company Offers Steps to Improve COPD Patients' Lives 3
(Date:11/22/2014)... Dylan Queen, a renowned brand in wedding dresses, has ... offers a wide range of special occasion dresses, shoes ... to create multiple looks easily. , According to the ... chic wedding dresses has been prepared for many months ... now. Dylan Queen can always create what ladies like, ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... 22, 2014 "My friend went in ... by the machine," said an inventor from Cambria Heights, ... go back a second time because the first results ... She developed the patent-pending MAMO EASY to offer a ... design saves the patient from the pain normally involved ...
(Date:11/22/2014)... SATURDAY, Nov. 22, 2014 (HealthDay News) -- The wide ... can pose a threat for people with food allergies, ... there are so many types of food allergies that ... over the holidays," Dr. Guha Krishnaswamy, director of allergy ... said in a hospital news release. "If you ...
(Date:11/22/2014)... This month has been a historical time for Angeldress.co.uk, ... positive reviews from some renowned review websites. Recently, the company ... a new selection of wonderful sexy wedding dresses to its ... shipping and up to an 80% discount on any order ... the most suitable dress at Angeldress.co.uk, which has garnered a ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... (Nasdaq: MTXX ), an over-the-counter healthcare company ... "Better Ways to Get Better(R)," announced today that financial ... 31, 2008, will be released after the market closes ... will be held the following morning on Tuesday, January ...
... In 2008, The Larry King Cardiac,Foundation, a nonprofit organization ... health insurance, increased the number of men and,women served ... expand its,national network of partner hospitals. , ... medical procedures,the Foundation helped save the lives of 313 ...
... Calif., Jan. 22 /PRNewswire/ -- Interactive lifestyle network ... newest tool in the fight against weight gain - The ... network and hsn.com on January 26. Developed by Dr. ... of his research linking human olfactory senses to appetite and ...
... a Boston-based company conceived in partnership with major ... Johnson & Johnson has joined the initiative. ... the opportunity to invest in the development of ... transform drug discovery and development and to apply ...
... Presented at This Week,s Keystone Symposium - Obesity: Novel ... Jan. 22 Interleukin Genetics, Inc. (NYSE Alternext US: ... research findings on the role genetics play in an ... following a calorie-restricted diet, during tomorrow,s Keystone Symposium titled, ...
... 22 Aero Financial, Inc, a strategic advisory and ... company has been retained as a strategic consulting partner ... natural health information and nutrition products.Pursuant to the consulting ... several facets of the company,s growth plans, including:, ...
Cached Medicine News:Health News:Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2009 Financial Results 2Health News:2008 a Year of Growth and Unprecedented Service for The Larry King Cardiac Foundation 2Health News:2008 a Year of Growth and Unprecedented Service for The Larry King Cardiac Foundation 3Health News:HSN to Debut Sensa Weight-Loss System January 26 2Health News:Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies 2Health News:Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies 3Health News:Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss 2Health News:Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss 3Health News:Aero Financial Retained as Strategic Consultant by Only Natures Finest(TM) 2
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Medicine Products: